Author: Minichart

us corporate news

MaxCyte, Inc. Receives Notice of Delisting or Failure to Satisfy a Continued Listing Rule – Form 8-K Filing March 2026

Minichart

March 21, 2026

MaxCyte, Inc. Receives Nasdaq Non-Compliance Notice for Mini...

Continue Reading 0

us corporate news

Oncolytics Biotech Inc. Adopts New Articles and Notice of Articles Following Continuance to British Columbia Corporate Law

Minichart

March 21, 2026

Oncolytics Biotech Inc. Announces Corporate Changes and Shar...

Continue Reading 0

us corporate news

Quince Therapeutics, Inc. 8-K Filing Details – Company Information, Address, and Nasdaq Listing (March 2026)

Minichart

March 21, 2026

Quince Therapeutics Receives Nasdaq Non-Compliance Notices: ...

Continue Reading 0

us corporate news

Columbia Sportswear $250 Million Credit Agreement With JPMorgan, Wells Fargo, and BofA – Key Terms and Definitions Explained

Minichart

March 21, 2026

Columbia Sportswear Company Files 8-K: New Credit Agreement ...

Continue Reading 0

us corporate news

Tamboran Announces JVSA Addendum Expanding Beetaloo Basin Phase 2 Development Area by 100,000 Acres – SEC Filing March 2026

Minichart

March 21, 2026

Tamboran Resources Corp 8-K Filing - Detailed Investor Updat...

Continue Reading 0

us corporate news

First Financial Corporation (THFF) 2025-2026 Financial Performance, Growth Strategy, and Key Investment Highlights

Minichart

March 21, 2026

First Financial Corporation (THFF) 2025-2026 Investor Update...

Continue Reading 0

us corporate news

NextEra Energy, Inc. SEC Filing: Corporate Units, Legal Opinions, and XBRL Taxonomy Details

Minichart

March 21, 2026

NextEra Energy, Inc. Announces \$600 Million Offering of Ser...

Continue Reading 0

us corporate news

Goodyear Tire & Rubber Company 8-K Filing March 2026: Corporate Details, Stock Information, and SEC Compliance

Minichart

March 21, 2026

Goodyear Tire & Rubber Company Announces Major EMEA Restruct...

Continue Reading 0

us corporate news

Relmada Therapeutics Reports Strong 2025 Results, $160M Financing, and Advances NDV-01 Bladder Cancer Program to Phase 3

Minichart

March 21, 2026

Relmada Therapeutics Reports Transformational 2025 Results, ...

Continue Reading 0

us corporate news

Core Molding Technologies Investor Presentation March 2026: Growth Strategy, Market Expansion, and Financial Highlights

Minichart

March 21, 2026

Core Molding Technologies Issues Investor Update: Strategic ...

Continue Reading 0